![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 31, 28819-28823, August 3, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Institute for Enzyme Research, the University of Tokushima, Tokushima 770-8503, Japan
Received for publication, February 26, 2001, and in revised form, May 17, 2001
| |
ABSTRACT |
|---|
|
|
|---|
In mammals, lipoate-activating enzyme (LAE)
catalyzes the activation of lipoate to lipoyl-nucleoside monophosphate.
The lipoyl moiety is then transferred to the specific lysine residue of
lipoate-dependent enzymes by the action of
lipoyltransferase. We purified LAE from bovine liver mitochondria to
apparent homogeneity. LAE activated lipoate with GTP at a 1000-fold
higher rate than with ATP. The reaction absolutely required lipoate,
GTP, and Mg2+ ion, and the reaction product was
lipoyl-GMP. LAE activated both (R)- and
(S)-lipoate to the respective lipoyl-GMP, although a preference for (R)-lipoate was observed. Similarly,
lipoyltransferase equally transferred both the (R)- and
(S)-lipoyl moieties from the respectively activated
lipoates to apoH-protein. Interestingly, however, only H-protein
carrying (R)-lipoate was active in the glycine cleavage
reaction. cDNA clones encoding a precursor LAE with a mitochondrial
presequence were isolated. The predicted amino acid sequence of LAE is
identical with that of xenobiotic-metabolizing/medium-chain fatty
acid:CoA ligase-III, but an amino acid substitution due to a single
nucleotide polymorphism was found. These results indicate that the
medium-chain acyl-CoA synthetase in mitochondria has a novel function,
the activation of lipoate with GTP.
Lipoic acid is a prosthetic group of H-protein of the glycine
cleavage system and the acyltransferase components (E2s) of the
pyruvate, The covalent attachment of lipoic acid occurs in two steps as
follows.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
-ketoglutarate, and branched-chain
-ketoacid
dehydrogenase complexes (1-4). The lipoyl moiety is attached to the
specific lysine residue of the proteins via an amide linkage. The
lipoyllysine arm is responsible for the shuttling of the reaction
intermediate and reducing equivalents between the active sites of the complexes.
Lipoate-protein ligase A of Escherichia coli catalyzes
both Reactions 1 and 2 (5). In contrast, the two reactions are catalyzed by separate enzymes in mammals; lipoate-activating enzyme (LAE)1 catalyzes Reaction 1 (6) and lipoyltransferase catalyzes Reaction 2 (7, 8). We demonstrated
the intramitochondrial lipoylation of in vitro translated
apoH-protein precursor (9) and purified lipoyltransferase from bovine
liver mitochondria (7). The purified enzyme efficiently transferred the
lipoyl moiety from lipoyl-AMP to H-protein and the lipoyl domains of
E2s of pyruvate,
-ketoglutarate, and branched-chain
-ketoacid
dehydrogenase complexes but had no ability to activate lipoate (8).
Despite an early finding of the presence of LAE in bovine liver, less
is known about the properties of the enzyme.
To better understand a mechanism of the protein lipoylation, we tried
to isolate an enzyme that catalyzes the activation of lipoic acid
employing a naturally occurring enantiomer of lipoic acid,
(R)-(+)-lipoic acid, as a substrate. Studies of the
intracellular distribution indicated that LAE activity was exclusively
localized in mitochondria when GTP was employed as a high energy
compound. The purified LAE utilized GTP preferentially for the
activation of lipoic acid. Nucleotide sequencing analysis of cDNAs
encoding the purified LAE revealed that the enzyme is identical with
xenobiotic-metabolizing/medium-chain fatty acid:CoA ligase-III (10).
The results indicate a novel function of the medium-chain acyl-CoA
synthetase employing GTP.
| |
EXPERIMENTAL PROCEDURES |
|---|
|
|
|---|
Materials--
Dexlipotam (tromethamine-salt of
(R)-(+)-lipoic acid) and (S)-(
)-lipoic acid
were generously provided by ASTA-Medica (Frankfurt am Main, Germany).
DNA restriction and modifying enzymes were purchased from Toyobo
(Tokyo, Japan), Takara Shuzo (Shiga, Japan), and New England Biolab.
(p-Amidinophenyl)methanesulfonyl fluoride hydrochloride (a-PMSF) was from Wako Pure Chemicals (Osaka,
Japan). DEAE-Sepharose, Blue-Sepharose, Superdex 200 prep grade,
PBETM 96, and Polybuffer 74 were purchased from
Amersham Pharmacia Biotech. ATP, GTP, CTP, and UTP were from Sigma.
Recombinant bovine apoH-protein and lipoyltransferase were purified as
described previously (7, 11).
Cell Fractionation-- Bovine liver was homogenized, and the mitochondrial fraction was prepared as described (2). The postmitochondrial supernatant was centrifuged at 10,000 × g for 10 min, and the supernatant obtained was further centrifuged at 144,000 × g for 1 h to obtain microsomal (pellet) and cytosolic (supernatant) fractions.
Purification of LAE-- All operations were carried out at 4 °C. Mitochondrial pellet (28 g) was suspended in 2 volumes of 15 mM potassium phosphate buffer, pH 7.4, 5% (v/v) glycerol, 1 mM DTT, 1 mM EDTA, 40 µM a-PMSF, and 10 µg/ml leupeptin and sonicated twice for 1 min. The sonicate was centrifuged at 105,000 × g for 1 h, and the supernatant was applied to a DEAE-Sepharose column (2.5 × 20 cm) equilibrated with buffer A (10 mM potassium phosphate buffer, pH 7.4, 5% (v/v) glycerol, 0.5 mM DTT, 0.5 mM EDTA, 10 µM a-PMSF). After the column was washed, the retained proteins were eluted with a NaCl gradient in buffer A. Active fractions eluted at about 40 mM NaCl were pooled, dialyzed against 3.5 mM potassium phosphate buffer, pH 7.4, 5% (v/v) glycerol, 0.5 mM DTT, 10 µM a-PMSF, and loaded onto a column of hydroxylapatite (2.5 × 5 cm) equilibrated with the same buffer. After washing, the column was developed with a potassium phosphate gradient, pH 7.4, containing 5% (v/v) glycerol, 0.5 mM DTT, and 10 µM a-PMSF. Active fractions eluted at about 35 mM potassium phosphate were concentrated with a YM-30 membrane (Millipore), dialyzed against buffer B (5 mM potassium phosphate buffer, pH 7.4, 10% (v/v) glycerol, 0.5 mM DTT, 0.5 mM EDTA, 10 µM a-PMSF), and applied to a Blue-Sepharose column (2 × 5 cm) equilibrated with buffer B. The retained proteins were eluted with a NaCl gradient in buffer B. Active fractions eluted at about 100 mM NaCl were concentrated and loaded on a Superdex 200 column (1.6 × 60 cm). The column was developed with 50 mM potassium phosphate buffer, pH 7.4, 10% (v/v) glycerol, 0.5 mM DTT, 0.5 mM EDTA, 10 µM a-PMSF, 150 mM NaCl, and active fractions were pooled.
Assay of LAE--
The activity of LAE was determined by the
following three ways. 1) LAE activity was routinely assayed by the
coupled method where lipoyl-GMP produced by LAE is immediately used by
lipoyltransferase to lipoylate apoH-protein. The reaction was
carried out in a 50-µl mixture containing LAE, 100 µM
(R)-lipoate, 20 mM Tris-HCl, pH 7.5, 4 mM GTP, 4 mM MgCl2, 0.5 mM DTT, 0.52 µg of purified bovine lipoyltransferase, 40 mM potassium phosphate buffer, pH 7.8, 0.3 mg/ml bovine
serum albumin, and 2 µg of apoH-protein at 37 °C for 1 h.
After terminating the reaction by heating the mixture, amounts of
heat-stable lipoylated H-protein in the mixture were determined by the
glycine-14CO2 exchange reaction as described
previously (7). 2) The HPLC method was performed in a 500-µl mixture
containing LAE, 100 µM (R)- or
(S)-lipoate, 50 mM
NaH2PO4-K2HPO4, pH 6.5, 4 mM GTP, 4 mM MgCl2, and 0.5 mM DTT at 37 °C for 1 h. After the reaction, the
mixture was transferred to a Microcon YM-30 (Millipore) and centrifuged. The product, lipoyl-GMP, in the filtrate was analyzed by
high performance liquid chromatography (HPLC) on an ODS column (4.6 × 250 mm, Tosoh, Japan). The column was developed with an acetonitrile gradient as described (12). Elution of lipoyl-GMP was
monitored at 252 nm (
252 = 13, 700). Standard
lipoyl-GMP was chemically synthesized from a mixture of
(R)- and (S)-lipoate (13). 3) The hydroxamate
method was carried out essentially as described (6) with some
modifications. The reaction was carried out in a 100-µl mixture
containing LAE, 2 mM (R)-lipoate, 4 mM ATP, 4 mM MgCl2, 100 mM Tris, and 100 mM NH2OH-HCl at
32 °C for 1 h.
Kinetic analysis was carried out with the coupled method. Apparent Km values for (R)-lipoate were determined at varied concentrations of (R)-lipoate with a constant concentration of nucleoside triphosphate at 4 mM. Apparent Km values for nucleoside triphosphate were determined at varied concentrations of nucleoside triphosphate with a constant concentration of (R)-lipoate at 25 µM (with ATP) or 100 µM (with GTP, CTP, or UTP).
Isolation and Sequencing of cDNA Clones--
DNA
manipulations were accomplished by standard techniques (14). Two
oligonucleotides were synthesized for screening. Probe 1 (5'-AA(A/G)GGIAA(T/C)AT(T/C/A)CA(A/G)CCICCIAA(T/C)AC-3') corresponds to
amino acid residues 404-412 (DDBJ/EMBL/GenBankTM accession
number AB048289), and Probe 2 (5'-CCIATITTICC(T/C)TCIGTITTIGGIGG-3') corresponds to amino acid residues 417-409. They were labeled with
[
-32P]ATP by T4 polynucleotide kinase and used to
screen a
gt10 bovine liver cDNA library
(CLONTECH). The hybridization and washing of Hybond
N+ membranes were carried out as described except that
washings were carried out at 51 and 41 °C with Probes 1 and 2, respectively (9). The insert cDNAs from positive clones were
sequenced employing a 373A DNA sequencer (PE Applied Biosystems).
Southern Blot Analysis-- Bovine genomic DNA (2.5 µg) was digested with EcoRV, BamHI, HindIII, KpnI, or SacI, separated on a 0.7% agarose gel, and transferred to Hybond N+ as described previously (11). The membranes were hybridized with a 32P-labeled 333-base pair cDNA fragment (nucleotides 1733-2065 (GenBankTM accession number AB048289)) synthesized by polymerase chain reaction. The hybridization and washing of the membrane were carried out according to the protocol provided by Amersham Pharmacia Biotech.
Other Methods--
The medium-chain acyl-CoA synthetase activity
was measured by the standard radioisotope method described by
Vessey et al. (15), and medium-chain acyl-GMP
formation was determined by the HPLC method for LAE described above.
The N-terminal amino acid sequences of the purified LAE and
lysylpeptides were determined as described previously (16). Assay of
lipoyltransferase were carried out as described (7). Chromatofocusing
of LAE was carried out with PBETM 94 and Polybuffer 74 according to a protocol provided by the manufacturer. Protein
concentrations were determined by the method of Bradford (17).
Native-PAGE and SDS-PAGE were carried out as described (2, 18).
| |
RESULTS AND DISCUSSION |
|---|
|
|
|---|
Purification of LAE-- To isolate LAE, we employed the coupled method for the detection of the enzyme. Mitochondrial, microsomal, and cytosolic fractions were separated from bovine liver homogenate, and LAE activities in each fraction was determined. Surprisingly, high activity (3400 nmol/h/g of liver) was observed in mitochondria when GTP was employed as a high energy compound, and more than 99% of the total activity was confined in mitochondria. In contrast, total activity assayed with ATP was extremely low (8.78 nmol/h/g of liver). Tsunoda and Yasunobu (6) demonstrated the presence of LAE in the postmitochondrial supernatant fraction of bovine liver, but we were not able to find significant activity in the cytosol from bovine liver. The mitochondrial localization of LAE is consistent with the observation that lipoyltransferase and the proteins to be lipoylated are localized in mitochondria. Therefore, we purified the GTP-dependent LAE from mitochondria. The mitochondrial extracts were applied to a DEAE-Sepharose column, and the column was developed with a NaCl gradient. Most of the activity (268.3 µmol/h) was recovered in fractions eluted at about 40 mM NaCl, whereas a very small amount of the activity was detected in the flow-through fractions (0.236 µmol/h). About half of the activity in the flow-through fraction was precipitated by centrifugation at 144,000 × g for 1 h, suggesting that the activity is still bound to fragments of mitochondrial membranes. Further characterization of the activity in the flow-through fraction has not been performed because the activity is negligible compared with that in the 40-mM NaCl fraction. LAE in the 40-mM NaCl fraction was purified further by successive chromatographies on hydroxylapatite, Blue-Sepharose, and Superdex 200 columns. Throughout these purification steps, a single peak of LAE activity was observed, and elution profiles determined by the coupled method and the hydroxamate method were parallel (not shown). A summary of the purification is shown in Table I. Activities by the coupled method with ATP were less than 1% of those by the hydroxamate method throughout the purification (data not shown). Because hydroxylamine reacts even with the enzyme-bound lipoyl-AMP, a marked difference between the activities determined by the coupled method with ATP and the hydroxamate method suggests that the lipoyl-AMP produced is hardly released from the enzyme. The final purified preparation represented a 39-fold purification with a yield of 16% over the extracts when measured by the coupled method and was apparently homogeneous on SDS-PAGE (not shown). The molecular mass of LAE was determined to be 61 kDa by SDS-PAGE, whereas it was 49 kDa by gel filtration chromatography on Superdex 200. An isoelectric point of 5.67 was obtained by chromatofocusing. An optimal pH of the LAE reaction was determined to be 6.6 by the HPLC method. However, the reaction in the coupled method was carried out at a higher pH, because lipoyltransferase has a strict optimal pH at 7.9 (7).
|
Catalytic Properties-- The requirements for LAE reaction were determined by the coupled method. The removal of (R)-lipoate, GTP, or MgCl2 from the reaction mixture resulted in no holoH-protein formation, indicating that the reaction was absolutely dependent on (R)-lipoate, GTP, and MgCl2. With (S)-lipoate, holoH-protein formation was less than 1% of that with (R)-lipoate, the naturally occurring enantiomer. Removal of lipoyltransferase also resulted in no holoH-protein formation, indicating that LAE has no ability to transfer the activated lipoate to apoH-protein.
Steady state kinetic analyses were carried out with various nucleoside triphosphates. The reaction exhibited typical Michaelis-Menten kinetics with respect to both substrates. As shown in Table II, Vmax(app) values with GTP, CTP, and UTP were about 1000-fold greater than with ATP. The result indicates that lipoyl-nucleoside monophosphates, other than lipoyl-AMP, that are formed are rapidly released from LAE and utilized by lipoyltransferase. The affinity for GTP was higher than for ATP. Although the Km(app) value for (R)-lipoate was higher with GTP than with ATP, the catalytic efficiency, Vmax(app)/Km(app), was much higher with GTP than with ATP. The low Km(app) value for lipoate with ATP may reflect the situation that LAE can not respond to the increase in the concentration of lipoate because of limited release of the product. The concentration of GTP in mitochondria is reported to be in the range of 0.15 to 0.23 mM (19). These observations strongly support the concept that GTP is involved in the activation of lipoate in mitochondria. It is unlikely that CTP and UTP are involved in the activation because the Km(app) values for the nucleotides and lipoate are relatively high.
|
Analysis of the Reaction Product--
The product of LAE reaction
was analyzed by the HPLC method. Authentic lipoyl-GMP prepared from
(R,S)-lipoic acid eluted at 20.9, 23.9, and 25.6 min (Fig.
1A,a). The difference in the
retention time presumably depends on the ionized state of lipoyl-GMP.
The retention times of the products were similar to those of the
standard lipoyl-GMP (Fig. 1A, c and d). The
amount of (R)-lipoyl-GMP was calculated to be 2475 pmol, and
a specific activity of 9940 nmol/h/mg of protein was obtained. The
value was in good agreement with that obtained by the coupled method
(Tables I and II). The formation of (S)-lipoyl-GMP (1597 pmol) was 64.5% of the (R)-lipoyl-GMP formation. The peak
fractions were collected, and an aliquot of (R)-lipoyl-GMP
or (S)-lipoyl-GMP was subjected to the lipoyltransferase reaction. The lipoylated H-protein was then analyzed by native-PAGE and
the glycine-14CO2 exchange activity. The
lipoylated H-protein migrates faster than apoH-protein on native-PAGE
because of reduction of a positive charge of the lysine residue to be
lipoylated (2). As shown in Fig. 1B, apoH-protein (7.1 pmol)
is completely lipoylated by lipoyltransferase with 20 pmol of
(R)-lipoyl-GMP. The lipoylated H-protein exhibited the
glycine-14CO2 exchange activity of 7.51 nmol/30
min, corresponding to 9.74 pmol of lipoylated H-protein (Fig.
1C). Interestingly, lipoyltransferase could transfer the
lipoyl moiety from (S)-lipoyl-GMP to H-protein as well as
from (R)-lipoyl-GMP (Fig. 1B). However, it was
clearly demonstrated for the first time that only H-protein having the (R)-lipoyl moiety was active in the glycine cleavage system
(Fig. 1C). The very low exchange activity with
(S)-lipoylated H-protein may be attributed to the
contamination of (R)-lipoate.
|
Kinetic Properties of Lipoyltransferase-- The high rate of lipoylation with GTP in the coupled method described above strongly indicates that lipoyltransferase is able to utilize lipoyl-GMP as a substrate. To confirm this, we examined the kinetic properties of lipoyltransferase using chemically synthesized lipoyl-GMP. As shown in Table III, lipoyltransferase utilized lipoyl-GMP as well as lipoyl-AMP, although the affinity for lipoyl-GMP was about three times lower than that for lipoyl-AMP.
|
Cloning and Sequencing of cDNAs for LAE--
The
N-terminal amino acid sequence analysis showed that the purified LAE
had heterogeneous N termini. They start from leucine (58%, amino acid
32 (GenBankTM accession number AB048289)), serine
(8%, amino acid 33), glycine (9%, amino acid 34), and alanine (25%,
amino acid 35). We then obtained several lysylpeptides and analyzed the
N-terminal amino acid sequence to synthesize oligonucleotide probes
based on the sequences. The oligonucleotides were employed for the
screening of a
gt10 bovine liver cDNA library. Approximately
4 × 105 independent clones were screened, and 18 positive clones were obtained. Five clones containing full-length
cDNA for LAE were chosen randomly, and the nucleotide sequences
were analyzed. The longest cDNA consists of 2114 base pairs and
contains an open reading frame of 1731 base pairs. The cDNA encodes
for 577 amino acids, including a mitochondrial presequence of 31 amino
acid residues and a mature LAE of 546 amino acid residues. The
predicted presequence shows a characteristic feature, being rich
in basic amino acid residues, and an absence of acidic amino acid
residues. The nucleotide sequence has been submitted to the
DDBJ/EMBL/GenBankTM with accession number AB048289. The
calculated molecular mass of the mature LAE of 61,146 Da is in good
agreement with that determined by SDS-PAGE. The sequence
CCACTATGC surrounding the first in-frame ATG codon matches the optimum
translation initiation sequence, CC(A/G)CCATGG, described by Kozak
(20). A putative polyadenylation signal, AATAAA, is located 18 base
pairs upstream from the poly(A) tail. The amino acid sequence of LAE
contains a putative AMP/ATP binding motif common to acyl-CoA synthetase (21). Amino acid sequence homology search by FASTA and BLAST showed
that the sequence of LAE was identical to that of
xenobiotic-metabolizing/medium-chain fatty acid:CoA ligase-III from
bovine liver, although the mitochondrial presequence has not been
predicted (10). The cDNA obtained extends by 28 nucleotides
upstream from the reported 5'-end. Furthermore, the following
differences from the sequence reported were observed. First, a single
nucleotide substitution of G for A at nucleotide position 1244 (GenBankTM accession number AB048289) was found in
four of five clones analyzed, and consequently an amino acid
substitution of alanine for threonine was predicted at position 372. Amino acid sequence analysis of a lysylpeptide obtained from purified
LAE showed the amino acid residue at position 372 to be alanine.
Second, an insertion of 39 nucleotides (nucleotides 80-118
(GenBankTM accession number AB048289)) due to an
alternative splicing was found in two of five clones.
Southern blot analysis was carried out to examine whether more than
one gene encoding LAE was present in a genome, because two distinct
cDNA containing a different nucleotide at the position 1244 were
isolated from a cDNA library. As shown in Fig.
2, a single band was detected in each of
the enzyme digests, indicating the presence of a single copy of the
gene encoding LAE. The result suggests that the difference of
the nucleotide at position 1244 should be due to a single
nucleotide polymorphic mutation.
|
Relationship between Medium-chain Acyl-CoA Synthesis and Lipoate Activation-- We next examined whether the purified LAE can catalyze acyl-CoA synthesis. Table IV shows that the purified enzyme exhibited activities of medium-chain acyl-CoA synthesis with the highest specific activity with hexanoic acid. The data are consistent with those of bovine mitochondrial xenobiotic-metabolizing/medium chain-fatty acid:CoA lygase III reported previously (15, 22). Because LAE utilizes GTP, acyl-GMP formation was examined. A broad substrate specificity was observed with respect to the chain length of fatty acids (Table IV). The formation of lipoyl-GMP was comparable with that of decanoyl-GMP.
|
To explore the relationship between the lipoate activation and the acyl-CoA synthesis, the effects of lipoate and GTP on the acyl-CoA synthesis (with ATP) were investigated. When hexanoate was the fatty acid substrate, synthesis of hexanoyl-CoA was reduced by 65% (with 0.1 mM lipoate) and 52% (with 2 mM GTP). The inhibitions by lipoate and GTP were competitive with respect to hexanoate and ATP, respectively (Ki for lipoate, 3.9 ± 0.3 µM; Km(app) for hexanoate, 5.9 ± 1.3 µM; Ki for GTP, 0.58 ± 0.13 mM; Km(app) for ATP, 0.32 ± 0.10 mM; n = 3). Similarly, lipoyl-GMP formation was inhibited by substrates for acyl-CoA synthesis. The addition of 0.25 mM CoA and 0.1 mM hexanoate inhibited the reaction by 52 and 15%, respectively. The addition of 2 mM ATP inhibited the reaction nearly completely (residual activity was 1.4% of that of control) because the lipoyl-AMP formed could hardly dissociate from LAE. The inhibition by ATP was slightly relieved in the presence of 0.25 mM CoA to 5.6% residual activity (586 nmol/h/mg of protein) with concomitant synthesis of lipoyl-CoA (13269 nmol/h/mg of protein). Although the rate of lipoyl-GMP formation in this situation is very low, it is about 40-fold greater than that of lipoyl-AMP formation (Table II). These results suggest that GTP and lipoate share the binding site with ATP and fatty acid, respectively, on LAE and that LAE can catalyze the lipoyl-GMP formation in mitochondria where ATP, CoA, and GTP coexist. It is unclear at present whether there is some biochemical mechanism responsible for the preferential production of lipoyl-GMP in mitochondria.
Conclusions--
This work characterizes the LAE reaction and
demonstrates a novel function of the medium-chain acyl-CoA synthetase
in mitochondria. Although ATP has been recognized as a substrate for
lipoate activation, the present study demonstrates that LAE catalyzes
the activation of lipoate utilizing GTP and easily releases the
product, lipoyl-GMP, from the active site to provide a substrate for
lipoyltransferase. In contrast, ATP is an essential substrate for the
acyl-CoA synthesis because the reaction intermediate, acyl-AMP, has to
be retained on the active site of the enzyme to react with CoA. We
could not detect a significant amount of lipoate-activating
activity other than the purified LAE in mitochondria, and we
therefore conclude that the enzyme reported here is primarily
responsible for the activation of lipoate in mitochondria.
| |
ACKNOWLEDGEMENTS |
|---|
We thank ASTA-Medica for the generous gift of
(R)-(+)- and (S)-(
)-lipoate and Ryoichi
Kunai (University of Tokushima) for amino acid sequencing.
| |
FOOTNOTES |
|---|
* This investigation was supported in part by grants from the Ministry of Education, Science, and Culture of Japan.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AB048289.
To whom correspondence should be addressed. Tel.: 81-88-633-7426;
Fax: 81-88-633-7428; E-mail:motokawa@ier.tokushima-u.ac.jp.
Published, JBC Papers in Press, May 29, 2001, DOI 10.1074/jbc.M101748200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: LAE, lipoate-activating enzyme; a-PMSF, (p-amidinophenyl)methanesulfonyl fluoride hydrochloride; DTT, dithiothreitol; HPLC, high performance liquid chromatography; PAGE, polyacrylamide gel electrophoresis.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Fujiwara, K., Okamura-Ikeda, K., and Motokawa, Y. (1986) J. Biol. Chem. 261, 8836-8841 |
| 2. | Fujiwara, K., Okamura-Ikeda, K., and Motokawa, Y. (1992) J. Biol. Chem. 267, 20011-20016 |
| 3. | Perham, R. N. (1991) Biochemistry 30, 8501-8512 |
| 4. | Reed, L. J., and Hackert, M. L. (1990) J. Biol. Chem. 265, 8971-8974 |
| 5. | Morris, T. W., Reed, K. E., and Cronan, J. E., Jr. (1994) J. Biol. Chem. 269, 16091-16100 |
| 6. | Tsunoda, J. N., and Yasunobu, K. T. (1967) Arch. Biochem. Biophys. 118, 395-401 |
| 7. | Fujiwara, K., Okamura-Ikeda, K., and Motokawa, Y. (1994) J. Biol. Chem. 269, 16605-16609 |
| 8. | Fujiwara, K., Okamura-Ikeda, K., and Motokawa, Y. (1996) J. Biol. Chem. 271, 12932-12936 |
| 9. | Fujiwara, K., Okamura-Ikeda, K., and Motokawa, Y. (1990) J. Biol. Chem. 265, 17463-17467 |
| 10. | Vessey, D. A., Lau, E., and Kelley, M. (2000) J. Biochem. Mol. Toxicol. 14, 11-19 |
| 11. | Fujiwara, K., Okamura-Ikeda, K., and Motokawa, Y. (1997) J. Biol. Chem. 272, 31974-31978 |
| 12. | Kishore, N. S., Lu, T., Knoll, L. J., Katoh, A., Rudnick, D. A., Mehta, P. P., Devadas, B., Huhn, M., Atwood, J. L., Adams, S. P., Gokel, G. W., and Gordon, J. I. (1991) J. Biol. Chem. 266, 8835-8855 |
| 13. | Reed, L. J., Leach, F. R., and Koike, M. (1958) J. Biol. Chem. 232, 123-142 |
| 14. | Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , 2nd Ed. , Cold Spring Harbor Laboratory, Cold Spring Harbor, NY |
| 15. | Vessey, D. A., Kelly, M., Lau, E., and Zhang, S. Z. (2000) J. Biochem. Mol. Toxicol. 14, 162-168 |
| 16. | Okamura-Ikeda, K., Fujiwara, K., and Motokawa, Y. (1999) Eur. J. Biochem. 264, 446-452 |
| 17. | Bradford, M. M. (1976) Anal. Biochem. 72, 248-254 |
| 18. | Laemmli, U. K. (1970) Nature 227, 680-685 |
| 19. | Smith, C. M., Bryla, J., and Williamson, J. R. (1974) J. Biol. Chem. 249, 1497-1505 |
| 20. | Kozak, M. (1987) J. Mol. Biol. 196, 947-950 |
| 21. | Stuhlsatz-Krouper, S. M., Bennett, N. E., and Schaffer, J. E. (1998) J. Biol. Chem. 273, 28642-28650 |
| 22. | Vessey, D. A., and Hu, J. (1995) J. Biochem. Toxicol. 10, 329-337 |
This article has been cited by other articles:
![]() |
D. J. Kim, K. H. Kim, H. H. Lee, S. J. Lee, J. Y. Ha, H. J. Yoon, and S. W. Suh Crystal Structure of Lipoate-Protein Ligase A Bound with the Activated Intermediate: INSIGHTS INTO INTERACTION WITH LIPOYL DOMAINS J. Biol. Chem., November 11, 2005; 280(45): 38081 - 38089. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhang, A. K. Joshi, J. Hofmann, E. Schweizer, and S. Smith Cloning, Expression, and Characterization of the Human Mitochondrial {beta}-Ketoacyl Synthase: COMPLEMENTATION OF THE YEAST CEM1 KNOCK-OUT STRAIN J. Biol. Chem., April 1, 2005; 280(13): 12422 - 12429. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |